Suchergebnisse - "Muscle, Skeletal/drug effects"

  1. 1
  2. 2
  3. 3

    Quelle: Naunyn Schmiedebergs Arch Pharmacol

  4. 4

    Quelle: Cell Commun Signal
    Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-12 (2024)
    Cell communication and signaling, vol. 22, no. 1, pp. 595

    Dateibeschreibung: application/pdf

  5. 5
  6. 6

    Quelle: Pflugers Arch

  7. 7

    Weitere Verfasser: Giuseppe De Vito Joan M. G. Senden Davide Susta et al.

    Quelle: Am J Clin Nutr
    The American Journal of Clinical Nutrition
    Murphy, C H, Flanagan, E M, De Vito, G, Susta, D, Mitchelson, K A J, de Marco Castro, E, Senden, J M G, Goessens, J P B, Mikłosz, A, Chabowski, A, Segurado, R, Corish, C A, McCarthy, S N, Egan, B, van Loon, L J C & Roche, H M 2021, 'Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial', The American Journal of Clinical Nutrition, vol. 113, no. 6, pp. 1411–1427. https://doi.org/10.1093/ajcn/nqaa449

    Dateibeschreibung: application/pdf

  8. 8

    Weitere Verfasser: Cornel C. Sieber S. Wijers Lorenzo M. Donini et al.

    Quelle: Aging Clin Exp Res

    Dateibeschreibung: application/pdf

  9. 9

    Quelle: The Journal of Nutrition. 148:712-720

  10. 10

    Quelle: Jensen, R C, Lehman Christensen, L, Nielsen, J, Schrøder, H D, Kvorning, T, Gejl, K D, Højlund, K, Glintborg, D & Andersen, M 2018, ' Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training : a randomized, double-blinded, placebo-controlled trial ', Andrology, vol. 6, no. 4, pp. 547-555 . https://doi.org/10.1111/andr.12492

    Dateibeschreibung: application/pdf

  11. 11

    Quelle: International Journal of Neuroscience. 128:412-420

  12. 12

    Quelle: Journal of Visualized Experiments.

  13. 13
  14. 14

    Quelle: Osteoporos Int
    Bolʹ, Sustavy, Pozvonočnik, Vol 3, Iss 1.09, Pp 18-24 (2013)
    Bolʹ, Sustavy, Pozvonočnik, Vol 3, Iss 2.10, Pp 11-21 (2013)
    Osteoporosis international, 23 Suppl 1
    PAIN. JOINTS. SPINE; № 2.10 (2013); 11-21
    Боль. Суставы. Позвоночник-Bolʹ, sustavy, pozvonočnik; № 2.10 (2013); 11-21
    Біль. Суглоби. Хребет-Bolʹ, sustavy, pozvonočnik; № 2.10 (2013); 11-21
    PAIN. JOINTS. SPINE; № 1.09 (2013); 18-24
    Боль. Суставы. Позвоночник-Bolʹ, sustavy, pozvonočnik; № 1.09 (2013); 18-24
    Біль. Суглоби. Хребет-Bolʹ, sustavy, pozvonočnik; № 1.09 (2013); 18-24

    Schlagwörter: Male, Medicine (General), Endocrinology, Diabetes and Metabolism, Selective Estrogen Receptor Modulators -- pharmacology -- therapeutic use, 0302 clinical medicine, Neoplasms, Monoclonal, Diphosphonates/pharmacology/therapeutic use, Vitamin D, Human health sciences, Humanized, Bone Density Conservation Agents, Diphosphonates, Vitamin D/pharmacology/therapeutic use, Antibodies, Monoclonal, Strontium ranelate, Sciences bio-médicales et agricoles, Muscle, Skeletal -- drug effects, Middle Aged, Cardiovascular Diseases/chemically induced, Stroke -- chemically induced, 3. Good health, Vitamin D -- pharmacology -- therapeutic use, Stroke, Osteoporosis -- drug therapy, Bone Density Conservation Agents -- pharmacology -- therapeutic use, Cardiovascular Diseases, Dietary Supplements -- adverse effects, Muscle, Monoclonal -- pharmacology, Female, Muscle, Skeletal/drug effects, Denosumab, Cardiovascular Diseases -- chemically induced, Médecine générale & interne, Osteoporosis/drug therapy, Selective Estrogen Receptor Modulators, Consensus, Antibodies, Monoclonal -- pharmacology, Calcium/pharmacology/therapeutic use, Selective Estrogen Receptor Modulators/pharmacology/therapeutic use, Neoplasms -- chemically induced, Thiophenes/pharmacology, Thiophenes -- pharmacology, Antibodies, Monoclonal, Humanized, Sciences de la santé humaine, Antibodies, 03 medical and health sciences, R5-920, Stroke/chemically induced, Diphosphonates -- pharmacology -- therapeutic use, Organometallic Compounds, Bisphosphonate, Humans, Muscle, Skeletal, Aged, Calcium -- pharmacology -- therapeutic use, Consensus Statement, SERM, Antibodies, Monoclonal/pharmacology, Organometallic Compounds/pharmacology, Neoplasms/chemically induced, Dietary Supplements, Bone Density Conservation Agents/pharmacology/therapeutic use, Osteoporosis, Calcium, Skeletal -- drug effects, Dietary Supplements/adverse effects, General & internal medicine, Organometallic Compounds -- pharmacology

    Dateibeschreibung: 1 full-text file(s): application/pdf; text/html; application/pdf

  15. 15
  16. 16

    Quelle: Minshull, C, Biant, L C, Ralston, S H & Gleeson, N 2016, 'A Systematic Review of the Role of Vitamin D on Neuromuscular Remodelling Following Exercise and Injury', Calcified Tissue International, vol. 98, no. 5, pp. 426-37. https://doi.org/10.1007/s00223-015-0099-x

    Dateibeschreibung: application/pdf

  17. 17

    Quelle: Biomed Res Int

    Dateibeschreibung: text/xhtml; application/pdf

  18. 18
  19. 19

    Quelle: Hostrup, M, Kalsen, A, Ørtenblad, N, Juel, C, Mørch, K, Rzeppa, S, Karlsson, S, Backer, V & Bangsbo, J 2014, ' β2-Adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise-induced reductions in Na+-K+-ATPase Vmax in trained men ', Journal of Physiology, vol. 592, no. 24, pp. 5445-5459 . https://doi.org/10.1113/jphysiol.2014.277095

    Dateibeschreibung: application/pdf

  20. 20

    Quelle: Diabetes